Topical treatment with 5% imiquimod for solitary keratoacanthoma

Yong Ju Kim, Eul Sang Hwang, Sang Wook Son, Il-Hwan Kim

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Keratoacanthoma is a rapidly growing tumor, histologically resembling squamous cell carcinoma. Although it may regress spontaneously, keratoacanthoma is routinely treated by excision. Here we report the successful therapeutic use of imiquimod 5% cream for the treatment of keratoacanthoma. The patient was 35-year old Korean man with solitary dome-shaped nodule on his nose. On the basis of clinical and histopathological examination, the diagnosis of solitary keratoacanthoma of mature stage was made. The tumor mass fully regressed under topical treatment with imiquimod 5% cream within 38 days. No recurrence occurred during a six months follow up period. Imiquimod can be an effective non-operative therapeutic modality for keratoacanthoma.

Original languageEnglish
Pages (from-to)1321-1324
Number of pages4
JournalKorean Journal of Dermatology
Volume42
Issue number10
Publication statusPublished - 2004 Oct 1

Fingerprint

imiquimod
Keratoacanthoma
Therapeutics
Therapeutic Uses
Nose
Squamous Cell Carcinoma
Neoplasms
Recurrence

Keywords

  • Imiquimod
  • Keratoacanthoma

ASJC Scopus subject areas

  • Dermatology

Cite this

Topical treatment with 5% imiquimod for solitary keratoacanthoma. / Kim, Yong Ju; Hwang, Eul Sang; Son, Sang Wook; Kim, Il-Hwan.

In: Korean Journal of Dermatology, Vol. 42, No. 10, 01.10.2004, p. 1321-1324.

Research output: Contribution to journalArticle

@article{5c86e53e65374585ac4b54a6281d8a22,
title = "Topical treatment with 5{\%} imiquimod for solitary keratoacanthoma",
abstract = "Keratoacanthoma is a rapidly growing tumor, histologically resembling squamous cell carcinoma. Although it may regress spontaneously, keratoacanthoma is routinely treated by excision. Here we report the successful therapeutic use of imiquimod 5{\%} cream for the treatment of keratoacanthoma. The patient was 35-year old Korean man with solitary dome-shaped nodule on his nose. On the basis of clinical and histopathological examination, the diagnosis of solitary keratoacanthoma of mature stage was made. The tumor mass fully regressed under topical treatment with imiquimod 5{\%} cream within 38 days. No recurrence occurred during a six months follow up period. Imiquimod can be an effective non-operative therapeutic modality for keratoacanthoma.",
keywords = "Imiquimod, Keratoacanthoma",
author = "Kim, {Yong Ju} and Hwang, {Eul Sang} and Son, {Sang Wook} and Il-Hwan Kim",
year = "2004",
month = "10",
day = "1",
language = "English",
volume = "42",
pages = "1321--1324",
journal = "Korean Journal of Dermatology",
issn = "0494-4739",
publisher = "Korean Dermatological Association",
number = "10",

}

TY - JOUR

T1 - Topical treatment with 5% imiquimod for solitary keratoacanthoma

AU - Kim, Yong Ju

AU - Hwang, Eul Sang

AU - Son, Sang Wook

AU - Kim, Il-Hwan

PY - 2004/10/1

Y1 - 2004/10/1

N2 - Keratoacanthoma is a rapidly growing tumor, histologically resembling squamous cell carcinoma. Although it may regress spontaneously, keratoacanthoma is routinely treated by excision. Here we report the successful therapeutic use of imiquimod 5% cream for the treatment of keratoacanthoma. The patient was 35-year old Korean man with solitary dome-shaped nodule on his nose. On the basis of clinical and histopathological examination, the diagnosis of solitary keratoacanthoma of mature stage was made. The tumor mass fully regressed under topical treatment with imiquimod 5% cream within 38 days. No recurrence occurred during a six months follow up period. Imiquimod can be an effective non-operative therapeutic modality for keratoacanthoma.

AB - Keratoacanthoma is a rapidly growing tumor, histologically resembling squamous cell carcinoma. Although it may regress spontaneously, keratoacanthoma is routinely treated by excision. Here we report the successful therapeutic use of imiquimod 5% cream for the treatment of keratoacanthoma. The patient was 35-year old Korean man with solitary dome-shaped nodule on his nose. On the basis of clinical and histopathological examination, the diagnosis of solitary keratoacanthoma of mature stage was made. The tumor mass fully regressed under topical treatment with imiquimod 5% cream within 38 days. No recurrence occurred during a six months follow up period. Imiquimod can be an effective non-operative therapeutic modality for keratoacanthoma.

KW - Imiquimod

KW - Keratoacanthoma

UR - http://www.scopus.com/inward/record.url?scp=10644283069&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=10644283069&partnerID=8YFLogxK

M3 - Article

VL - 42

SP - 1321

EP - 1324

JO - Korean Journal of Dermatology

JF - Korean Journal of Dermatology

SN - 0494-4739

IS - 10

ER -